KRAS and neoplasm: Although the detection rate of KRAS alterations in our study was somewhat lower (83%) than that reported in another extensive targeted sequence analysis (95%)16 or in a whole‐exome sequence analysis (95%),14 these studies selected samples with enough tumor cellularity or concentrated tumor cells from tumor xenografts.